Literature DB >> 11412134

Cytokines and oxidative signalling in skeletal muscle.

M B Reid1, Y P Li.   

Abstract

A growing body of literature indicates that cytokines regulate skeletal muscle function, including gene expression and adaptive responses. Tumour necrosis factor-alpha (TNF-alpha) is the cytokine most prominently linked to muscle pathophysiology and, therefore, has been studied most extensively in muscle-based systems. TNF-alpha is associated with muscle catabolism and loss of muscle function in human diseases that range from cancer to heart failure, from arthritis to AIDS. Recent advances have established that TNF-alpha causes muscle weakness via at least two mechanisms, accelerated protein loss and contractile dysfunction. Protein loss is a chronic response that occurs over days to weeks. Changes in gene expression required for TNF-alpha induced catabolism are regulated by the transcription factor nuclear factor-kappaB which is essential for the net loss of muscle protein caused by chronic TNF-alpha exposure. Contractile dysfunction is an acute response to TNF-alpha stimulation, developing over hours and resulting in decreased force production. Both actions of TNF-alpha involve a rapid rise in endogenous oxidants as an essential step in post-receptor signal transduction. These oxidants appear to include reactive oxygen species derived from mitochondrial electron transport. Such information provides insight into the cellular and molecular mechanisms of TNF-alpha action in skeletal muscle and establishes a scientific basis for continued research into cytokine signalling.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11412134     DOI: 10.1046/j.1365-201x.2001.00824.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  40 in total

Review 1.  Making the case for skeletal myopathy as the major limitation of exercise capacity in heart failure.

Authors:  Holly R Middlekauff
Journal:  Circ Heart Fail       Date:  2010-07       Impact factor: 8.790

2.  Hypoxaemia enhances peripheral muscle oxidative stress in chronic obstructive pulmonary disease.

Authors:  C Koechlin; F Maltais; D Saey; A Michaud; P LeBlanc; M Hayot; C Préfaut
Journal:  Thorax       Date:  2005-06-17       Impact factor: 9.139

3.  Diaphragm weakness and proteomics (global and redox) modifications in heart failure with reduced ejection fraction in rats.

Authors:  Rachel C Kelley; Brian McDonagh; Babette Brumback; Glenn A Walter; Ravneet Vohra; Leonardo F Ferreira
Journal:  J Mol Cell Cardiol       Date:  2020-02-05       Impact factor: 5.000

4.  TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle.

Authors:  Yi-Ping Li; Yuling Chen; Joseph John; Jennifer Moylan; Bingwen Jin; Douglas L Mann; Michael B Reid
Journal:  FASEB J       Date:  2005-03       Impact factor: 5.191

5.  Role of TNF-{alpha} signaling in regeneration of cardiotoxin-injured muscle.

Authors:  Shuen-Ei Chen; Eric Gerken; Yingmin Zhang; Mei Zhan; Raja K Mohan; Andrew S Li; Michael B Reid; Yi-Ping Li
Journal:  Am J Physiol Cell Physiol       Date:  2005-08-03       Impact factor: 4.249

Review 6.  Does antioxidant vitamin supplementation protect against muscle damage?

Authors:  Cian McGinley; Amir Shafat; Alan E Donnelly
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

7.  The effects of pentoxifylline on skeletal muscle contractility and neuromuscular transmission during hypoxia.

Authors:  Fatma Simsek-Duran; Mert Ertunc; Rustu Onur
Journal:  Indian J Pharmacol       Date:  2009-10       Impact factor: 1.200

8.  Hormone therapy attenuates exercise-induced skeletal muscle damage in postmenopausal women.

Authors:  Christina M Dieli-Conwright; Tanya M Spektor; Judd C Rice; F R Sattler; E Todd Schroeder
Journal:  J Appl Physiol (1985)       Date:  2009-07-02

9.  Metabolic derangements in the gastrocnemius and the effect of Compound A therapy in a murine model of cancer cachexia.

Authors:  Hirak Der-Torossian; Ashley Wysong; Scott Shadfar; Monte S Willis; Jonathan McDunn; Marion E Couch
Journal:  J Cachexia Sarcopenia Muscle       Date:  2013-01-24       Impact factor: 12.910

10.  Chronic heart failure and exercise intolerance: the hemodynamic paradox.

Authors:  Kent R Nilsson; Brian D Duscha; Patrick M Hranitzky; William E Kraus
Journal:  Curr Cardiol Rev       Date:  2008-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.